Biomerica Unit Is Issued a Patent for Allergy Treatment Method

Biomerica Inc. said its Allergy Immuno Technologies Inc. unit has been issued a patent for a new method of treating allergies.

In a press release, the company said the latest patent covers an invention under which an allergen--the material to which a patient is allergic--is combined with something called a biological response modifier. The patent covers a class of such modifiers.

Biomerica said it plans to enter a “collaborative arrangement” with a drug company to use the invention. In the meantime, the company said, it intends to raise funds necessary for its allergy unit to begin marketing the new treatments.